Considering that complement activation itself can contribute to vasculitis or thrombotic conditions, TSP-1 may also be involved in mitigating the sequelae of an overactive complement system, further preventing anaphylatoxin C3a and C5a formation (18, 19, 47). This evidence concerns the gene THBS1 and vasculitis.